PharmaEngine Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,584	993.7	875.62	1,769	2,151
Short-Term Investments	3,133	2,867	2,752	1,837	1,663
Trading Asset Securities	-	-	-	55.59	-
Cash & Short-Term Investments	4,717	3,861	3,628	3,661	3,814
Cash Growth	22.17%	6.42%	-0.91%	-4.00%	12.37%
Accounts Receivable	262.44	1,844	174.17	160.34	160.48
Other Receivables	54.25	87.59	97.41	63.51	22.83
Receivables	316.69	1,932	271.58	223.85	183.31
Inventory	39.87	28.38	15.9	34.38	5.43
Prepaid Expenses	11.46	6.4	7.48	6.57	6.48
Other Current Assets	-	-	-	-	0.08
Total Current Assets	5,085	5,827	3,923	3,926	4,009
Property, Plant & Equipment	44.68	10.24	18.03	25.92	7.89
Other Intangible Assets	1.1	1.78	1.88	2.51	0.6
Long-Term Deferred Tax Assets	14.36	5.91	8	9.54	4.98
Other Long-Term Assets	2.53	2.44	2.98	2.5	3.9
Total Assets	5,148	5,848	3,954	3,967	4,026
Accounts Payable	35.58	-	-	-	-
Accrued Expenses	-	99.31	67.22	61.31	64.14
Current Portion of Leases	8.66	7.14	7.67	7.54	7.59
Current Income Taxes Payable	30.11	327.9	-	-	6.92
Other Current Liabilities	112.8	8.7	8.98	9.9	9.06
Total Current Liabilities	187.15	443.05	83.86	78.74	87.71
Long-Term Leases	33.46	-	7.14	14.81	-
Long-Term Deferred Tax Liabilities	0.99	4.96	-	0.92	-
Total Liabilities	221.59	448.01	91.01	94.47	87.71
Common Stock	1,457	1,457	1,457	1,457	1,466
Additional Paid-In Capital	1,616	1,616	1,616	1,617	1,620
Retained Earnings	1,987	2,461	925.31	937.85	1,101
Treasury Stock	-133.41	-133.41	-133.41	-133.41	-248.24
Comprehensive Income & Other	-	-0.41	-1.79	-5.97	-
Shareholders' Equity	4,926	5,400	3,863	3,872	3,939
Total Liabilities & Equity	5,148	5,848	3,954	3,967	4,026
Total Debt	42.12	7.14	14.81	22.35	7.59
Net Cash (Debt)	4,675	3,854	3,613	3,639	3,806
Net Cash Growth	21.30%	6.65%	-0.71%	-4.39%	12.88%
Net Cash Per Share	32.44	26.78	25.14	25.32	26.30
Filing Date Shares Outstanding	143.31	143.68	143.68	143.69	143.6
Total Common Shares Outstanding	143.31	143.68	143.68	143.69	143.6
Working Capital	4,898	5,384	3,839	3,847	3,921
Book Value Per Share	34.37	37.58	26.89	26.95	27.43
Tangible Book Value	4,925	5,398	3,861	3,870	3,938
Tangible Book Value Per Share	34.37	37.57	26.87	26.93	27.42
Machinery	-	5.18	4.44	4.03	0.8
Leasehold Improvements	-	-	7.69	7.69	7.69

Source: S&P Global Market Intelligence. Standard template. Financial Sources.